Activist & passive stakes
Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
All filings, new and amended.1–8 of 8
- PassiveAmendment 2Below 5%Nov 14, 2026Chernett Jorey3.47% · 886,148 shSEC
- PassiveAmendment 2Nov 13, 2026Blue Owl Capital Holdings LP9.11% · 1,135,081 shSEC
- PassiveNewNov 13, 2026Eventide Asset Management, LLC5.4% · 2,446,789 shSEC
- PassiveAmendment 8Below 5%Nov 13, 2026NMSIC Co-Investment Fund, L.P.3.39% · 863,958 shSEC
- PassiveAmendment 1Below 5%Nov 13, 2026AQR Capital Management, LLC0.64% · 633,393 shSEC
- PassiveNewNov 10, 2026State Street Corporation7.6% · 7,538,078 shSEC
- PassiveAmendment 1Below 5%Nov 10, 2026The Goldman Sachs Group, Inc.0% · 0 shSEC
- PassiveAmendment 4Below 5%Nov 6, 2026Wellington Management Group LLP0.9% · 1,869,523 shSEC
| Filing | Symbol | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|---|
PassiveAmendment 2Below 5% | XGN | Chernett Jorey in Exagen Inc. | 3.47% | 886,148 | Nov 14, 2026 | SEC |
PassiveAmendment 2 | IMA | Blue Owl Capital Holdings LP in ImageneBio, Inc. | 9.11% | 1,135,081 | Nov 13, 2026 | SEC |
PassiveNew | AGEN | Eventide Asset Management, LLC in Agenus Inc | 5.4% | 2,446,789 | Nov 13, 2026 | SEC |
PassiveAmendment 8Below 5% | XGN | NMSIC Co-Investment Fund, L.P. in Exagen Inc. | 3.39% | 863,958 | Nov 13, 2026 | SEC |
PassiveAmendment 1Below 5% | RARE | AQR Capital Management, LLC in Ultragenyx Pharmaceutical Inc. | 0.64% | 633,393 | Nov 13, 2026 | SEC |
PassiveNew | RARE | State Street Corporation in Ultragenyx Pharmaceutical Inc | 7.6% | 7,538,078 | Nov 10, 2026 | SEC |
PassiveAmendment 1Below 5% | TNMG | The Goldman Sachs Group, Inc. in Tnl Mediagene | 0% | 0 | Nov 10, 2026 | SEC |
PassiveAmendment 4Below 5% | QGEN | Wellington Management Group LLP in Qiagen N.V. | 0.9% | 1,869,523 | Nov 6, 2026 | SEC |